Generics, Supergenerics and Patent Strategies (2012)

SMi Introduce their 15th Annual Generics, Supergenerics and Patent Strategies Conference:

The pharmaceutical generics industry is a fast moving and consistently expanding one. With the much referenced patent cliff rapidly approaching for many and already passed for some all businesses are looking to generics for a source of additional revenue. For the big Parma companies these generics ventures are interesting diversification opportunities to add to their portfolio. For the generics companies themselves there is an opportunity to partner up with these industry heavyweights and perhaps make the most of the partnerships to launch new branded generics which may have the potential to become best sellers in their own right. Along with the opportunities generics offer there is also a minefield of IP and patent issues along with regional regulations and marketplace differences to contend with before you can get your products to market. SMi's conference will provide you with an excellent overview of the industry at the moment. You will hear case studies from the big players in the market showing how they have handled issues and how they see the industry moving forward. We will also be covering some of the current regulatory issues and also the big Parma perspective of their movements in the generic field.

Key Reasons to Attend: Hear from expert speakers on the current state of the Generics markets. Discuss strategies for making the best use of branded and super-generics. Analyse the recent trend of Big Pharma moving into the Generics field. Learn about recent Generics case law and how the outcomes affect your business. Network  with senior representatives and key decision makers within Generics.